| Title: | Cancer-driving mutations are enriched in genic regions intolerant to germline variation |
| Journal: | Science Advances |
| Published: | 26 Aug 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/36026442/ |
| DOI: | https://doi.org/10.1126/sciadv.abo6371 |
| URL: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417173 |
Publication 7565
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Large reference datasets of protein-coding variation in human populations have allowed us to determine which genes and genic subregions are intolerant to germline genetic variation. There is also a growing number of genes implicated in severe Mendelian diseases that overlap with genes implicated in cancer. We hypothesized that cancer-driving mutations might be enriched in genic subregions that are depleted of germline variation relative to somatic variation. We introduce a new metric, OncMTR (oncology missense tolerance ratio), which uses 125,748 exomes in the Genome Aggregation Database (gnomAD) to identify these genic subregions. We demonstrate that OncMTR can significantly predict driver mutations implicated in hematologic malignancies. Divergent OncMTR regions were enriched for cancer-relevant protein domains, and overlaying OncMTR scores on protein structures identified functionally important protein residues. Last, we performed a rare variant, gene-based collapsing analysis on an independent set of 394,694 exomes from the UK Biobank and find that OncMTR markedly improves genetic signals for hematologic malignancies.11 Authors
- Dimitrios Vitsios
- Ryan S Dhindsa
- Dorota Matelska
- Jonathan Mitchell
- Xuequing Zou
- Joshua Armenia
- Fengyuan Hu
- Quanli Wang
- Ben Sidders
- Andrew R Harper
- Slavé Petrovski
Enabling scientific discoveries that improve human health